2018 GA meeting: May 3rd in Belgium

2017 GA MEETING

The 2017 GA meeting took place on Thursday 4 May in Karlsruhe, Germany and was a resounding success with attendance reaching 60% - the highest since 2010. Hosted by Cronimet Holding GmbH, the meeting lasted 5 hours with several key decisions taken by way of vote.

Some highlights:

  • Change of Governance: Election of Tim Hird (Prince-Erachem) as Chairman; Dr Bernd Friede (Elkem) as First Vice Chair; Arnaud Vigier (Eramet) as Second Vice Chair; and Dr Doreen McGough (MARA) as Secretary General
  • Approval of an established SIEF data-sharing model in accordance with regulation 2016/9
  • Approval of the 2017 workplan and budget
  • Approval of plan to share consortium-owned OECD/GLP studies for K-REACH registration purposes
Letters of Access for Referral (LoA)

Letters of Access for Referral (LoA)

A Letter of Access for Referral (LoA) to the LR Dossier is available to all potential registrants who elect not to join the Mn REACH Consortium. The Mn-based substances for which a LoA is available are indicated in the table below:

Substance name EINECS CAS SIEF-nominated Lead Registrant
Manganese 231-105-1 7439-96-5 South32 (2015 nomination)
Manganese oxide* 215-695-8 1344-43-0 Prince-Erachem
Manganese dioxide 215-202-6 1313-13-9 Tosoh Hellas A.I.C.
Trimanganese tetraoxide* 215-266-5 1317-35-7 Prince-Erachem
Manganese carbonate* 209-942-9 598-62-9 Prince-Erachem
Manganese sulphate* 232-089-9 7785-87-7 Prince-Erachem
Manganese dinitrate* 233-828-8 10377-66-9 Prince-Erachem
Slags, FeMn-manufacturing 273-728-1 69012-28-8 Ferroatlantica, S.L.
Slags, SiMn-manufacturing 273-733-9 69012-33-5 Ferroatlantica, S.L.
Manganese ores, reduced 273-748-0 69012-49-3 Glencore Manganese France
Manganese dichloride* 231-869-6 7773-01-5 Prince-Erachem
Manganese sulphide 242-599-3 18820-29-6 Höganäs AB


 * for these specific substances, joint-registrants will need to agree to the terms of the LR Agreement issued by Prince-Erachem before the LoA and registration token are provided.
 

  • A template Chemical Safety Report (CSR) is supplied with the LoA. The CSR shall be submitted separately as part of each registrant's company specific information. The template CSR part B shall be modified by the registrant to include its own or its downstream users’ specific uses. The registrant shall also complete the CSR part A. Adapting and updating the CSR is the responsibility of each registrant.
  • Any potential REACH registrant can purchase a LoA/template CSR.
  • A LoA/CSR shall be purchased for each substance and per legal entity registrant.
  • An Only Representative (OR) of one or more non-EU manufacturers shall purchase a LoA/CSR for each substance and for each non-Community manufacture that has appointed that OR.
  • Each registrant is fully responsible for the use of the LoA/CSR in its own registration and for completing its registration before the corresponding tonnage deadline.
  • The REACH-IT security token and joint submission name will accompany the LoA/CSR.
  • The consortium does not offer advice or guidance on the use of the LoA/CSR or the completion of the IUCLID 5 joint-submission process.


To purchase a Letter of Access for referral (LoA), go to the following web portal to begin the process: http://manganese.webregistrationserver.com.


About cookies on our website

Following a revised EU directive on website cookies, each company based, or doing business, in the EU is required to notify users about the cookies used on their website.

Our site uses cookies to improve your experience of certain areas of the site and to allow the use of specific functionality like social media page sharing. You may delete and block all cookies from this site, but as a result parts of the site may not work as intended.

To find out more about what cookies are, which cookies we use on this website and how to delete and block cookies, please see our Which cookies we use page.

Click on the button below to accept the use of cookies on this website (this will prevent the dialogue box from appearing on future visits)